Accéder au contenu
Merck

Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety.

Contraception (2003-09-05)
Carolyn Westhoff
RÉSUMÉ

Depot-medroxyprogesterone acetate (Depo-Provera(R)) is a highly effective, nondaily hormonal contraceptive option that has been available in the United States for a decade, and worldwide for 40 years. Benefits and risks of hormonal therapy are often under scrutiny; however, long-term clinical experience has established the safety of this long-acting contraceptive. This article reviews the contraceptive efficacy, potential noncontraceptive health benefits and long-term safety of with regard to risk of cardiovascular events, breast and gynecologic malignancy and osteopenia. Comparisons with other hormonal contraceptives are made as clinically appropriate. Common patient management issues, including effects on menstrual cycle, body weight and mood, are also addressed. Finally, this review provides recommendations for appropriate patient selection.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Medroxyprogesterone 17-acetate, ≥97% (HPLC)
USP
Medroxyprogesterone 17-acetate, United States Pharmacopeia (USP) Reference Standard
Supelco
Medroxyprogesterone 17-acetate, VETRANAL®, analytical standard
Medroxyprogesterone 17-acetate, European Pharmacopoeia (EP) Reference Standard
Medroxyprogesterone 17-acetate, European Pharmacopoeia (EP) Reference Standard
Medroxyprogesterone 17-acetate, European Pharmacopoeia (EP) Reference Standard